drug protocol number

EFC18243

drug sponsor

Sanofi Arabia Trading Company Limited / ArabMed CRO

drug study

Lunsekimig

drug trial site

King Khalid University Hospital (Riyadh), King Abdulaziz Medical City NG (Jeddah), King Fahad Medical City  (Riyadh)

drug status

Ongoing

drug phase